MedPath

Pediatric Spinal Muscular Atrophy (SMA) China Registry

Recruiting
Conditions
Muscular Atrophy, Spinal
Registration Number
NCT05042921
Lead Sponsor
Biogen
Brief Summary

The primary objective of the study is to describe the natural history and utilization of disease modifying therapy (DMT) treatments among pediatric Chinese participants with spinal muscular atrophy linked to chromosome 5q (5q-SMA). The study will examine SMA natural history and DMT outcomes in a real-world setting both prospectively and retrospectively.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
600
Inclusion Criteria
  • Ability of the participant and/or his/her legally authorized representative (e.g., parent or legal guardian), as appropriate and applicable, to understand the purpose and risks of the study, to provide informed consent, and to authorize the use of confidential health information in accordance with national and local privacy regulations.
  • Genetically confirmed 5q-SMA.
  • Age < 18 years at enrollment.

Key

Exclusion Criteria
  • Unable or unwilling to provide informed consent.
  • Other types of SMA (non 5q-SMA).

NOTE: Other protocol defined inclusion/ exclusion criteria may apply.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Natural History and Utilization of Disease Modifying Therapy (DMT) Treatments Among Pediatric Chinese Participants With Spinal Muscular Atrophy Linked to Chromosome 5q (5q-SMA)Up to 60 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (25)

Xiamen Maternal and Child Health Hospital

🇨🇳

Xiamen, Fujian, China

The First Affiliated Hospital, Sun Yat-sen University

🇨🇳

Guangzhou, Guangdong, China

Anhui Children's Hospital

🇨🇳

Hefei, Anhui, China

Shenzhen Children's Hospital

🇨🇳

Shenzhen, Guangdong, China

Maternity and Child Health Care of Guangxi Zhuang Autonomous Region

🇨🇳

Nanning, Guangxi, China

The Second Hospital of Hebei Medical University

🇨🇳

Shijiazhuang, Hebei, China

The Third Affiliated Hospital of Zhengzhou University

🇨🇳

Zhengzhou, Henan, China

Wuhan Children's Hospital, Tongji Medical College Huazhong University of Science & Technology

🇨🇳

Wuhan, Hubei, China

Xiangya Hospital, Central South University

🇨🇳

Changsha, Hunan, China

The Affiliated Hospital of Inner Mongolia Medical University

🇨🇳

Hohhot, Inner Mongolia, China

The First Hospital of Jilin University

🇨🇳

Changchun, Jilin, China

Children's Hospital Affiliated to Shandong University

🇨🇳

Jinan, Jinan Shandong, China

Children's Hospital of Fudan University

🇨🇳

Shanghai, Shanghai, China

Dalian Women and Children's Medical Group

🇨🇳

Dalian, Liaoning, China

Shengjing Hospital of China Medical University

🇨🇳

Shenyang, Liaoning, China

People's Hospital of Ningxia Hui Autonomous Region

🇨🇳

YInchuan, Ningxia, China

West China Second University Hospital, Sichuan University

🇨🇳

Chengdu, Sichuan, China

Jiangxi Provincial Children's Hospital

🇨🇳

Nanchang, Jiangxi, China

Children's Hospital of Chongqing Medical University

🇨🇳

Chongqing, Chongqing, China

Beijing Children's Hospital, Capital Medical University

🇨🇳

Beijing, Beijing, China

Fujian Medical University Union Hospital

🇨🇳

Fuzhou, Fujian, China

Hunan Children's Hospital

🇨🇳

Changsha, Hunan, China

Xuzhou Central Hospital

🇨🇳

Xuzhou, Jiangsu, China

The Second Affiliated Hospital of Xi'An Jiaotong University

🇨🇳

Xi'an, Shanxi, China

The Children's Hospital, Zhejiang University School of Medicine

🇨🇳

Hangzhou, Zhejiang, China

© Copyright 2025. All Rights Reserved by MedPath